Innovation, collaboration, and creativity

A new approach for research and development.

Transforming early scientific innovations into business partnership opportunities.

Ponte Vecchio, Florence, Italy
May 3, 2018

NEOMED Institute partners with McGill University to identify small molecule inhibitors of a novel oncology target: Cut-Like Homeobox 1 (CUX1)

Read complete news
April 25, 2018

The NEOMED Institute is participating at the 2nd Annual 2018 Franco-Quebecois Forum - Innovation in health (FFQIS) in Paris

Read complete news
April 10, 2018

NEOMED Therapeutics 1 names Dr. Frank Giles as Chief Medical Officer

Read complete news
image articles

See all the news

Portfolio

Our portfolio is managed according to industry standards, reducing the execution risk and maximizing value creation and the chances of commercial success.

Technoparc Montreal Site

Saint-Laurent

A high-tech research and development facility dedicated to the development of small molecule therapeutics, located in Technoparc Montréal’s Saint-Laurent Campus, acting as an open-access drug discovery hub, housing commercial companies and offering a unique environment to nurture collaboration, innovation, and creativity.

Learn more

Laval Biotech Site

Laval

A high-tech research and development facility dedicated to the development of biologics and vaccines, located in Laval, acting as an open-access drug discovery hub, housing commercial companies and offering a unique environment to nurture collaboration, innovation, and creativity.

Learn more
© 2018 NEOMED Institute. All Rights Reserved. // Solutions Web Globalia